Echocardiographic and clinical abnormalities in patients with psoriasis

被引:40
作者
Biyik, I.
Narin, A.
Bozok, M. A.
Ergene, O.
机构
[1] Usak State Hosp, Dept Cardiol, Usak, Turkey
[2] Usak State Hosp, Dept Dermatol, Usak, Turkey
[3] Ataturk Training & Res Hosp, Dept Cardiol, Izmir, Turkey
关键词
psoriasis; echocardiography; diastolic dysfunction; hypertension; valve disease;
D O I
10.1177/147323000603400608
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We investigated the incidence and severity of echocardiographic and clinical abnormalities in patients with psoriasis and their relationship to the severity, duration and type of psoriasis and other related factors. A total of 216 psoriasis patients and 216 control subjects were included in this study. Left and right heart dimensions, wall thicknesses, wall motion abnormalities, valvular disturbances, and systolic and diastolic functions were examined using two-dimensional and Doppler echocardiographic techniques. Left ventricular hypertrophy, left ventricular diastolic dysfunction, left ventricular wall motion abnormalities and valvular pathologies, especially mitral and tricuspid valve prolapse, were significantly more frequent in patients with psoriasis. Systolic and diastolic blood pressures were significantly higher in psoriasis patients. Significant correlations were found between: (i) psoriasis vulgaris and tricuspid valve prolapse; (ii) palmo-plantar psoriasis and valvular pathologies; and (iii) disease duration and left ventricular diastolic dysfunction and systolic and diastolic blood pressures. Physicians should be aware that cardiovascular abnormalities are common in patients with psoriasis.
引用
收藏
页码:632 / 639
页数:8
相关论文
共 28 条
[1]  
Ahmed Q, 1996, J RHEUMATOL, V23, P1107
[2]  
Badokin VV, 2004, TERAPEVT ARKH, V76, P56
[3]  
Cheitlin MD, 1997, CIRCULATION, V95, P1686
[4]  
Christophers E., 2003, FITZPATRICKS DERMATO, P407
[5]  
Fukuhara K, 1998, BRIT J DERMATOL, V138, P329
[6]   American Society of Echocardiography recommendations for use of echocardiography in clinical trials - A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Echocardiography in Clinical Trials [J].
Gottdiener, JS ;
Bednarz, J ;
Devereux, R ;
Gardin, J ;
Klein, A ;
Manning, WJ ;
Morehead, A ;
Kitzman, D ;
Oh, J ;
Quinones, M ;
Schiller, NB ;
Stein, JH ;
Weissman, NJ .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2004, 17 (10) :1086-1119
[7]  
GRIFFITHS CEM, 2004, ROOKS TXB DERMATOLOG, V2
[8]  
Guven A, 2003, T KLIN J CARDIOL, V16, P77
[9]   Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death [J].
Haider, AW ;
Larson, MG ;
Benjamin, EJ ;
Levy, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1454-1459
[10]  
HENSELER T, 1995, J AM ACAD DERMATOL, V32, P92